📊 VENAF Key Takeaways
Is MicroAlgo Inc. (VENAF) a Good Investment?
MicroAlgo exhibits severe operational dysfunction masked by massive revenue growth, likely from acquisition integration. Despite 32,649% revenue increase, the company is deeply unprofitable with negative operating cash flow of -2.8M, deteriorating net income (-181% YoY), and zero path to profitability visible in current fundamentals. While the fortress balance sheet ($21M cash, 0.0x debt) provides runway, the business model is not generating value—only burning it.
Why Buy MicroAlgo Inc. Stock? VENAF Key Strengths
- Fortress balance sheet with low leverage (0.0x debt/equity) and $21M cash reserves
- Exceptional revenue scale-up at 32,649% YoY growth indicating significant business expansion
- Strong liquidity position (6.98x current ratio) provides operational flexibility and runway
VENAF Stock Risks: MicroAlgo Inc. Investment Risks
- Persistent operating losses (-7.9% margin) and negative operating cash flow (-2.8M) despite extreme revenue growth signal structural profitability problems
- Net income deteriorating sharply (-181% YoY) while revenue explodes, indicating acquisition integration failure or unit economics collapse
- Low gross margin (27.8%) for software services; combined with negative operating margins, suggests cost structure misalignment and inability to scale profitably
- Negative FCF margin (-15.8%) and negative ROE/ROA (-1.9%/-1.7%) indicate value destruction for shareholders
- Financial data severely stale (March 2023); nearly 3 years old with no current visibility into operational trajectory
Key Metrics to Watch
- Operating cash flow trend and timeline to cash flow positivity
- Gross margin sustainability and operating expense ratio as percentage of revenue
- Operating margin trajectory and break-even analysis for current revenue base
- Cash burn rate and months of runway remaining at current burn rate
- Customer concentration, retention rate, and unit economics by customer segment
MicroAlgo Inc. (VENAF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.98x current ratio provides a solid financial cushion.
VENAF Profit Margin, ROE & Profitability Analysis
VENAF vs Technology Sector: How MicroAlgo Inc. Compares
How MicroAlgo Inc. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MicroAlgo Inc. Stock Overvalued? VENAF Valuation Analysis 2026
Based on fundamental analysis, MicroAlgo Inc. has mixed fundamental signals relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MicroAlgo Inc. Balance Sheet: VENAF Debt, Cash & Liquidity
VENAF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: MicroAlgo Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
VENAF Revenue Growth, EPS Growth & YoY Performance
VENAF Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2023 | $17.8M | -$96.3K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
MicroAlgo Inc. Dividends, Buybacks & Capital Allocation
VENAF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for MicroAlgo Inc. (CIK: 0001800392)
📋 Recent SEC Filings
❓ Frequently Asked Questions about VENAF
What is the AI rating for VENAF?
MicroAlgo Inc. (VENAF) has an AI rating of STRONG SELL with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are VENAF's key strengths?
Claude: Fortress balance sheet with low leverage (0.0x debt/equity) and $21M cash reserves. Exceptional revenue scale-up at 32,649% YoY growth indicating significant business expansion.
What are the risks of investing in VENAF?
Claude: Persistent operating losses (-7.9% margin) and negative operating cash flow (-2.8M) despite extreme revenue growth signal structural profitability problems. Net income deteriorating sharply (-181% YoY) while revenue explodes, indicating acquisition integration failure or unit economics collapse.
What is VENAF's revenue and growth?
MicroAlgo Inc. reported revenue of $17.8M.
Does VENAF pay dividends?
MicroAlgo Inc. does not currently pay dividends.
Where can I find VENAF SEC filings?
Official SEC filings for MicroAlgo Inc. (CIK: 0001800392) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is VENAF's EPS?
MicroAlgo Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is VENAF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, MicroAlgo Inc. has a STRONG SELL rating with 72% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is VENAF stock overvalued or undervalued?
Valuation metrics for VENAF: ROE of -1.9% (sector avg: 22%), net margin of -7.1% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy VENAF stock in 2026?
Our dual AI analysis gives MicroAlgo Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is VENAF's free cash flow?
MicroAlgo Inc.'s operating cash flow is $-2.8M, with capital expenditures of $54.5K. FCF margin is -15.8%.
How does VENAF compare to other Technology stocks?
Vs Technology sector averages: Net margin -7.1% (avg: 18%), ROE -1.9% (avg: 22%), current ratio 6.98 (avg: 2.5).